PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70/CD3ζ signalosome and downstream signaling to PKCθ

被引:596
作者
Sheppard, KA
Fitz, LJ
Lee, JM
Benander, C
George, JA
Wooters, J
Qiu, YC
Jussif, JM
Carter, LL
Wood, CR
Chaudhary, D
机构
[1] Wyeth Ayerst Res, Inflammat Dept, Cambridge, MA 02140 USA
[2] Wyeth Ayerst Res, Prot Technol Dept, Cambridge, MA 02140 USA
来源
FEBS LETTERS | 2004年 / 574卷 / 1-3期
关键词
TCR signaling; CD3 xi ITAM; ZAP70; immunoinhibition;
D O I
10.1016/j.febslet.2004.07.083
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Engagement of the immunoinhibitory receptor, programmed death-1 (PD-1) attenuates T-cell receptor (TCR)-mediated activation of IL-2 production and T-cell proliferation. Here, we demonstrate that PD-1 modulation of T-cell function involves inhibition of TCR-mediated phosphorylation of ZAP70 and association with CD3zeta. In addition, PD-1 signaling attenuates PKCtheta activation loop phosphorylation in a cognate TCR signal. PKCtheta has been shown to be required for T-cell IL-2 production. A phosphorylated PD-1 peptide, corresponding to the C-terminal immunoreceptor tyrosine-switch motif (ITSM), acts as a docking site in vitro for both SHP-2 and SHP-1, while the phosphorylated peptide containing the N-terminal PD-1 immunoreceptor tyrosine based inhibitory motif (ITIM) associates only with SHP-2. (C) 2004 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.
引用
收藏
页码:37 / 41
页数:5
相关论文
共 33 条
  • [1] Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes
    Agata, Y
    Kawasaki, A
    Nishimura, H
    Ishida, Y
    Tsubata, T
    Yagita, H
    Honjo, T
    [J]. INTERNATIONAL IMMUNOLOGY, 1996, 8 (05) : 765 - 772
  • [2] The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice
    Ansari, MJI
    Salama, AD
    Chitnis, T
    Smith, RN
    Yagita, H
    Akiba, H
    Yamazaki, T
    Azuma, M
    Iwai, H
    Khoury, SJ
    Auchincloss, H
    Sayegh, MH
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (01) : 63 - 69
  • [3] Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phosphatase SHP-2
    Barford, D
    Neel, BG
    [J]. STRUCTURE, 1998, 6 (03) : 249 - 254
  • [4] CTLA-4 regulates the requirement for cytokine-induced signals in TH2 lineage commitment
    Bour-Jordan, H
    Grogan, JL
    Tang, QZ
    Auger, JA
    Locksley, RM
    Bluestone, JA
    [J]. NATURE IMMUNOLOGY, 2003, 4 (02) : 182 - 188
  • [5] Blockade of programmed death-1 Ligands on dendritic cells enhances T cell activation and cytokine production
    Brown, JA
    Dorfman, DM
    Ma, FR
    Sullivan, EL
    Munoz, O
    Wood, CR
    Greenfield, EA
    Freeman, GJ
    [J]. JOURNAL OF IMMUNOLOGY, 2003, 170 (03) : 1257 - 1266
  • [6] The B7 family of ligands and its receptors: New pathways for costimulation and inhibition of immune responses
    Carreno, BM
    Collins, M
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2002, 20 : 29 - 53
  • [7] Carter LL, 2002, EUR J IMMUNOL, V32, P634, DOI 10.1002/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO
  • [8] 2-9
  • [9] Distinct T cell developmental consequences in humans and mice expressing identical mutations in the DLAARN motif of ZAP-70
    Elder, ME
    Skoda-Smith, S
    Kadlecek, TA
    Wang, FL
    Wu, J
    Weiss, A
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (01) : 656 - 661
  • [10] Expression and regulation of the PD-L1 immunoinhibitory molecule on microvascular endothelial cells
    Eppihimer, MJ
    Gunn, J
    Freeman, GJ
    Greenfield, EA
    Chernova, T
    Erickson, J
    Leonard, JP
    [J]. MICROCIRCULATION, 2002, 9 (02) : 133 - 145